Mandar V. Shah
48Patents
4h-index
24Co-inventors
63Inventor score
Filing activity: Jul 2, 1993 → Mar 21, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6486138B1 | Ophthalmic compositions containing galactomannan polymers and borate | Human Necessities | 52 | Expired |
| US6261547A | Gelling ophthalmic compositions containing xanthan gum | Human Necessities | 48 | Expired |
| US5478816A | Liquid vitamin formulations containing vitamin D esters | Chemistry; Metallurgy | 6 | Expired |
| US11285163B2 | Ophthalmic solution | Human Necessities | 4 | Active |
| US7169755B2 | Solution for removing cataracts via liquefracture | Human Necessities | 3 | Expired |
| US11298315B2 | Triamcinolone and moxifloxacin compositions | Human Necessities | 3 | Active |
| US11564931B2 | Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties | Human Necessities | 1 | Active |
| US7084130B2 | Intraocular irrigating solution having improved flow characteristics | Human Necessities | 1 | Expired |
| US11433115B2 | Glycopeptide antibiotics liquid formulations and methods and uses thereof | Human Necessities | 1 | Active |
| US11400100B2 | Effective benzalkonium chloride-free bimatoprost ophthalmic compositions | Human Necessities | 1 | Active |
| US11696910B2 | Buffer-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof | Human Necessities | 1 | Active |
| US11395831B2 | Combination products of tobramycin compounds and dexameihasone compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US7363928B2 | Dilution resistant viscoelastic compositions | Human Necessities | 0 | Expired |
| US11344566B2 | Tobramycin compound conjugates and derivative compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US11857538B2 | Stable pilocarpine formulations with modified buffer characteristics and related methods | Human Necessities | 0 | Active |
| US11850249B2 | Methods of efficiently reducing intraocular pressure | Human Necessities | 0 | Active |
| US9801813B2 | Preservative-free ophthalmic pharmaceutical formulation | Human Necessities | 0 | Active |
| US11786538B2 | Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties | Human Necessities | 0 | Active |
| US12343373B2 | Glycopeptide antibiotics liquid formulations and methods and uses thereof | Human Necessities | 0 | Active |
| US11590153B2 | Methods of treating eye disease with tobramycin-related compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US12016855B2 | Prednisolone and moxifloxacin compositions and methods | Human Necessities | 0 | Active |
| US12156868B2 | Formulations of pilocarpine and brimonidine compounds and related methods | Human Necessities | 0 | Active |
| US11857539B2 | Gel ophthalmic formulations of pilocarpine and brimonidine compounds and related methods | Human Necessities | 0 | Active |
| US11446242B2 | Suspension component-specific triamcinolone and moxifloxacin compositions and associated methods of use | Human Necessities | 0 | Active |
| US11471403B2 | Limited particle size triamcinolone and moxifloxacin compositions and associated methods of use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.